Abviris Deutschland GmbH products

Innovative solutions for the serological detection of HPV16 induced cancer. From a diagnostics point of view it is irrelevant to detect the very common HPV infections but rather important to identify HPV induced deseases. The presence of increased HPV16 L1 antibodies is a highly specific indicator for altered cells in patients which have not been vaccinated against HPV. An elevated level of these antibodies is linked to the presence of precancerous lesions or tumors. While serological methods for the early detection of these HPV induced tumors did not exist in the past, Abviris Deutschland has developed a rapid test for the detection of HPV16 L1 antibodies in blood or serum. The cut off value of the Prevo-Check® is adjusted to detect relevant antibody levels.